Cargando…

5-FU therapeutic drug monitoring as a valuable option to reduce toxicity in patients with gastrointestinal cancer

AIMS: 5-FU is used as the main backbone of chemotherapy regimens for patients with colorectal and other gastrointestinal cancers. Despite development of new strategies that allowed enhancing clinical effectiveness and tolerability of 5-FU, 10–30% of patients treated with 5-FU-based regimens experien...

Descripción completa

Detalles Bibliográficos
Autores principales:	Morawska, Katarzyna, Goirand, Françoise, Marceau, Laurine, Devaux, Madeline, Cueff, Adèle, Bertaut, Aurélie, Vincent, Julie, Bengrine-Lefevre, Leila, Ghiringhelli, François, Schmitt, Antonin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2018
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5837758/ https://www.ncbi.nlm.nih.gov/pubmed/29545919 http://dx.doi.org/10.18632/oncotarget.24338

Ejemplares similares

Association of 5-FU Therapeutic Drug Monitoring to DPD Phenotype Assessment May Reduce 5-FU Under-Exposure
por: Dolat, Marine, et al.
Publicado: (2020)

Retrospective evaluation of FOLFIRI3 alone or in combination with bevacizumab or aflibercept in metastatic colorectal cancer
por: Devaux, Madeline, et al.
Publicado: (2019)

Folfirinox in elderly patients with pancreatic or colorectal cancer-tolerance and efficacy
por: Guion-Dusserre, Jean-Florian, et al.
Publicado: (2016)

Capillary density has no value as an early biomarker of bevacizumab efficacy in metastatic colorectal cancers: a prospective clinical trial
por: Fumet, Jean-David, et al.
Publicado: (2017)

Phase I Dose-Escalation Trial of an Innovative Chemotherapy Regimen Combining a Fractionated Dose of Irinotecan Plus Bevacizumab, Oxaliplatin, 5-Fluorouracil, and Folinic Acid (bFOLFIRINOX-3) in Chemorefractory Metastatic Colorectal Cancer
por: Bellio, Hélène, et al.
Publicado: (2021)

Safety and efficacy of a docetaxel-5FU-oxaliplatin regimen with or without trastuzumab in neoadjuvant treatment of localized gastric or gastroesophageal junction cancer: A retrospective study
por: Basso, Valeria, et al.
Publicado: (2019)

Does mammogram attendance influence participation in cervical and colorectal cancer screening? A prospective study among 1856 French women
por: Bertaut, Aurélie, et al.
Publicado: (2018)

Seroprevalence of SARS-CoV-2 among the staff and patients of a French cancer centre after first lockdown: The canSEROcov study
por: Ladoire, Sylvain, et al.
Publicado: (2021)

Influence of primary tumor location and resection on survival in metastatic colorectal cancer
por: Tharin, Zoé, et al.
Publicado: (2020)

Management and Outcomes of Pancreatic Cancer in French Real-World Clinical Practice
por: Jooste, Valérie, et al.
Publicado: (2022)

Pulmonary Artery Banding is Still a Valuable Option
por: Durandy, Yves
Publicado: (2013)

Association of Anti-EGFR Antibody and MEK Inhibitor in Gynecological Cancer Harboring RAS Mutation: A Case Series
por: Niogret, Julie, et al.
Publicado: (2022)

SNaPshot as a Valuable Option for the Identification of Mutations in Myeloma
por: Moreaux, Jerome
Publicado: (2014)

Ribociclib: a valuable addition to treatment options in breast cancer?
por: Bartsch, Rupert
Publicado: (2017)

Subcutaneous Immunoglobulins are a Valuable Treatment Option in Myasthenia Gravis
por: Garnero, Martina, et al.
Publicado: (2018)

Precision medicine phase II study evaluating the efficacy of a double immunotherapy by durvalumab and tremelimumab combined with olaparib in patients with solid cancers and carriers of homologous recombination repair genes mutation in response or stable after olaparib treatment
por: Fumet, Jean-David, et al.
Publicado: (2020)

Baseline splenic volume as a surrogate marker of FOLFIRINOX efficacy in advanced pancreatic carcinoma
por: Aarnink, Anne, et al.
Publicado: (2018)

Adjuvant Chemotherapy, a Valuable Alternative Option in Selected Patients with Cervical Cancer
por: Li, Shuang, et al.
Publicado: (2013)

Completion pneumonectomy: a valuable option for lung cancer recurrence or new primaries
por: Subotic, Dragan, et al.
Publicado: (2018)

Radiotherapy Scheme Effect on PD-L1 Expression for Locally Advanced Rectal Cancer
por: Boustani, Jihane, et al.
Publicado: (2020)

5-FU Metabolism in Cancer and Orally-Administrable 5-FU Drugs
por: Miura, Koh, et al.
Publicado: (2010)

Stent extension into a single inflow vessel is a valuable option after endophlebectomy
por: van Vuuren, Timme MAJ, et al.
Publicado: (2017)

Heat shock and HSP70 regulate 5-FU-mediated caspase-1 activation in myeloid-derived suppressor cells and tumor growth in mice
por: Pilot, Thomas, et al.
Publicado: (2020)

Parallel evolution and differences in seroprevalence of SARS-CoV-2 antibody between patients with cancer and health care workers in a tertiary cancer centre during the first and second wave of COVID-19 pandemic: canSEROcov-II cross-sectional study
por: Ladoire, Sylvain, et al.
Publicado: (2022)

Phase Ib/II trial evaluating the safety, tolerability and immunological activity of durvalumab (MEDI4736) (anti-PD-L1) plus tremelimumab (anti-CTLA-4) combined with FOLFOX in patients with metastatic colorectal cancer
por: Fumet, Jean-David, et al.
Publicado: (2018)

Transplantation after blunt trauma to the liver: a valuable option or just a "waste of organs"?
por: Heuer, M, et al.
Publicado: (2010)

Is heart transplantation a valuable option in patients with diffuse systemic sclerosis and primary cardiac involvement?
por: Turcotte‐Gosselin, Frédéric, et al.
Publicado: (2019)

Total Thyroidectomy with Central Node Dissection is a Valuable Option in Papillary Thyroid Cancer Treatment
por: Pastorčić Grgić, Marija, et al.
Publicado: (2020)

Secondary Intention Healing of Nasal Ala and Tip Defects: A Simple and Valuable Treatment Option
por: Wen, Guangdong, et al.
Publicado: (2022)

Mechanism of acquired 5FU resistance and strategy for overcoming 5FU resistance focusing on 5FU metabolism in colon cancer cell lines
por: Suetsugu, Tomonari, et al.
Publicado: (2021)

Uncommon EGFR mutations in lung carcinoma: features and treatment outcomes in a retrospective French cohort
por: Tankere, Pierre, et al.
Publicado: (2022)

Ovarian cancer in the older patient: where are we now? What to do next?
por: Rousseau, Frédérique, et al.
Publicado: (2023)

Fiberoptic bronchoscopy, as a valuable diagnostic option in sputum negative pulmonary tuberculosis: A prospective study
por: Quaiser, Saif, et al.
Publicado: (2012)

Radiation-Associated Pemphigus Vulgaris in a Patient With Preceding Malignancy: Treatment With Rituximab as a Valuable Option
por: Schauer, Franziska, et al.
Publicado: (2020)

Implementation and use of whole exome sequencing for metastatic solid cancer
por: Réda, Manon, et al.
Publicado: (2020)

RAS status and neoadjuvant chemotherapy impact CD8+ cells and tumor HLA class I expression in liver metastatic colorectal cancer
por: Ledys, Fanny, et al.
Publicado: (2018)

Case report: 5-Fluorouracil treatment in patient with an important partial DPD deficiency
por: Schmitt, Antonin, et al.
Publicado: (2023)

Treatment Options in Gastrointestinal Cutaneous Fistulas
por: Ashkenazi, Itamar, et al.
Publicado: (2017)

Trends in molecular subtypes of breast cancer: description of incidence rates between 2007 and 2012 from three French registries
por: Cortet, Marion, et al.
Publicado: (2018)

OncoSNIPE® Study Protocol, a study of molecular profiles associated with development of resistance in solid cancer patients
por: Vachenc, Sébastien, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_uta25jks4615bajlm1p11bpua6